Acute myeloid leukaemia (in remission)

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
2 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
Mechanism of action (INN-stem analysis)
Antimetabolite 1 substance
BCL-2 inhibitor 1 substance
Phase III: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase III

1 trial
  • AbbVie Deutschland GmbH & Co. KG Commercial
    AZACITIDINE; VENETOCLAX
    2023-507221-42-00 7 countries 2020 n=41
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
AbbVie Deutschland GmbH & Co. KG Commercial 1 Phase III 0
New trials by year
2020
1
← All indication landscapes